These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15062747)

  • 1. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular anti-D globulin injection for treatment of chronic idiopathic thrombocytopenic purpura.
    Dutta TK; Hamide A; Goel A; Kashyap R; Ramesh J
    J Assoc Physicians India; 2000 Mar; 48(3):365. PubMed ID: 11229136
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia].
    Pfeilstöcker M; Waldner R; Reisner R; Heinz R; Pittermann E
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):220-4. PubMed ID: 7496120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.
    Sandler SG
    Curr Opin Hematol; 2001 Nov; 8(6):417-20. PubMed ID: 11604585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
    Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
    Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin anti-D for treatment of chronic ITP in children.
    Iacobini M; Duse M; Antonetti L; Smacchia MP; Schiavetti A
    Pediatr Blood Cancer; 2010 Dec; 55(7):1435. PubMed ID: 20981698
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?
    Garratty G
    Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.